Evidence map›Paper›PMID 24653576›Full record

ArticleAfrican journal of traditional, complementary, and alternative medicines : AJTCAM2014

Effects of Ixeris Chinensis (Thunb.) Nakai boiling water extract on hepatitis B viral activity and hepatocellular carcinoma.

Ko-Nien Shih, Wen-Tao Huang, Chung-Liang Chang, Chih-Chung Feng

Open access · diamondAbstract read
In one paragraph

Article in African journal of traditional, complementary, and alternative medicines : AJTCAM, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.5field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Hepatoprotective Effects ofMolecules (Basel, Switzerland) · 2022
    Article
  3. Ethnobotanical Survey on Bitter Tea in Taiwan.Frontiers in pharmacology · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Ko-Nien ShihDepartment of Radiological Technology, College of Medical Sciences and Technology, Yuanpei University, HsinChu City 30015, Taiwan.
Wen-Tao HuangDepartment of Radiological Technology, College of Medical Sciences and Technology, Yuanpei University, HsinChu City 30015, Taiwan.
Chung-Liang ChangDepartment of Environmental Engineering and Health, College of Health Sciences, Yuanpei University, HsinChu City 30015, Taiwan.
Chih-Chung FengCardiovascular Internal Medicine Department, Changhua Christian Hospital, Changhua, 50006, Taiwan.
Yuanpei University · TWChanghua Christian Hospital · TW

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundHepatitis B virus (HBV) infection and hepatocellular carcinoma are major diseases that affect the Taiwanese population. Therefore, the development of an alternative herbal medicine that can effectively treat these diseases is a research target. In this study, we tested Ixeris Chinensis (Thunb.) Nakai boiling water extract (ICTN BWE) in vitro and analysed its effects on the HBV and liver cancer. MATERIALS AND

methodsWe used a human liver cancer cell line (Hep3B, a cell line that continuously secretes HBV particles into a medium) as an experimental model for the screening of various ICTN BWE concentrations and their effects on the HBV in vitro.

resultsOur results showed that 75 µg/mL ICTN BWE downregulated the relative expression of the hepatitis B virus surface antigens (HBsAg) to 77.1%. Using the human liver cancer cell lines HuH-7 and HepG2, and 3-(4,5-dimethylthiazol-zyl)-2,5-diphenyl tetrazolium bromide (MTT) and tumour clonogenic assays, we then showed that ICTN BWE inhibits hepatocellular carcinoma growth.

conclusionFluorescent microscopy of DAPI(4',6-Diamidino-2-phenylindole)-stained nuclei and DNA fragmentation assays confirmed the inhibitory effects of ICTN BWE on liver tumour cell growth through induction of apoptosis.

Indexed as

AsteraceaePhytotherapyAntineoplastic Agents, PhytogenicApoptosisCarcinoma, HepatocellularDown-RegulationHepatitis BHepatitis B Surface AntigensHepatitis B virusHep G2 CellsHumansLiver NeoplasmsPlant ExtractsAntineoplastic Agents, PhytogenicHepatitis B Surface AntigensPlant Extractsantihepatitis B virusantihepatocellular carcinomaapoptosisherbal medicineIxeris Chinensis (Thunb.) Nakai

Identifiers

PMID24653576
PMCPMC3957264
OpenAlexW2041149169

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.